Ocean Biomedical Debuts as Publicly Traded Company
By Exec Edge Editorial Staff Biopharma company Ocean Biomedical (Nasdaq: OCEA) began trading publicly today...
By Exec Edge Editorial Staff Biopharma company Ocean Biomedical (Nasdaq: OCEA) began trading publicly today...
By Exec Edge Editorial Staff Whether you’re saving for retirement or simply want to increase...
By Exec Edge Editorial Staff It’s hard to believe that we are completing a three-year...
By Exec Edge Editorial Staff GoodFill USA, LLC will introduce the first smartphone app dedicated...
By Exec Edge Editorial Staff G-P (Globalization Partners) said it hit $300 million in annual recurring revenue,...
By Exec Edge Editorial Staff Moody’s Investors Service said it upgraded Bowlero Corp.’s (NYSE: BOWL)...
By Exec Edge Editorial Staff Just a few years ago, the word “omnichannel” was rarely...
Spiraling healthcare costs have become a recurring problem for companies and many of their stakeholders,...
By Exec Edge Editorial Staff The Boston area is a challenging place to be a...
By Exec Edge Editorial Staff Immunotherapy-focused SAB Biotherapeutics, Inc. (Nasdaq: SABS) announced today that the...